5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The China Cardiovascular Devices Market is segmented by device type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices)
The increasing incidence of cardiovascular diseases and the growing geriatric population are the most significant factors driving the growth of the market.
According to a report by the United Nations Department of Economic and Social Affairs, more than 11% of China's Population is aged 65 years or over in 2019. Furthermore, China’s population is aging at a faster rate than almost all other countries of the Asia-Pacific region, which is in part due to the long run of China’s one-child policy and dramatic increase in healthcare facilities. The aging process is commonly associated with increased vascular rigidity and decreased vascular compliance. Elderly patients have a high risk of developing cardiovascular disorders, such as peripheral arterial disease (PAD), aortic disease, and venous thromboembolism (VTE). This is primarily due to age-related alterations in vascular structure and rigidity, further compounded by longer exposure to cardiovascular disease (CVD) risk factors. Furthermore, other factors, such as the rapid technological advances, and increasing awareness among population are also supplementing the market growth.
As per the scope of the report the market is segmented into diagnostic and monitoring devices, and therapeutic and surgical devices sub-segments. Moreover, the diagnostic and monitoring devices segment is further subdivided into an electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices. Similarly, the therapeutic and surgical devices segment is subdivided into cardiac assist devices, cardiac rhythm management device, catheter, grafts, heart valves, stents, and other therapeutic and surgical devices.
|By Device Type|
Report scope can be customized per your requirements. Click here.
On the diagnostic and monitoring front, new generation of portable and compact ECG are driving their greater adoption, especially in the home healthcare segment. The rising awareness and demand for minimally-invasive surgeries are driving the demand for coronary stents and valves. According to National Center for Cardiovascular Diseases, in 2017, there were around 290 million patients suffering from cardiovascular disease in China. Furthermore, rising geriatric population and increasing incidence rates of cardiovascular diseases, such as arrhythmias, stroke, and high blood pressure, are driving the demand for cardiac rhythm management devices, including pacemakers and implantable defibrillators.
To understand key trends, Download Sample Report
Several local players, along with global medical device manufacturers. operate in the Chinese market. Local players dominate in the stent, catheter, and graft segments. However, the quality of products from global companies is perceived as superior. Thus, the premium segment of cardiovascular devices market is dominated by global manufacturers.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Technological Advances to Boost the Market Growth
4.2.2 Growing Public Awareness and Government Initiatives
4.3 Market Restraints
4.3.1 Shortage of Skilled Medical Professionals
4.3.2 High Cost of Instruments and Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Diagnostic and Monitoring Devices
18.104.22.168 Electrocardiogram (ECG)
22.214.171.124 Remote Cardiac Monitoring
126.96.36.199 Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic and Surgical Devices
188.8.131.52 Cardiac Assist Devices
184.108.40.206 Cardiac Rhythm Management Device
220.127.116.11 Heart Valves
18.104.22.168 Other Therapeutic and Surgical Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Mindray Medical International Limited
6.1.4 Edwards Lifesciences
6.1.5 W.L. Gore & Associates Inc.
6.1.6 Medtronic PLC
6.1.7 Lepu Medical Technology (Beijing) Co. Ltd
6.1.8 Terumo Corporation
6.1.9 Microport Scientific Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments